HCC represents the terminal stage of NAFLD, suggesting that the regulatory mechanism of miR-221/222 on CDKN1B may play a vital role in the etiology of NAFLD. Here, CDKN1B is linked to metabolic dysfunction-associated steatotic liver disease.